What is the Ownership and Shareholding Structure of Leiutis Pharmaceuticals?
In 2020, Leiutis Pharmaceuticals had a promoter holding of 48.00% and a public holding of 52.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX